174 related articles for article (PubMed ID: 23360234)
21. Gene expression signatures defining fundamental biological processes in pluripotent, early, and late differentiated embryonic stem cells.
Gaspar JA; Doss MX; Winkler J; Wagh V; Hescheler J; Kolde R; Vilo J; Schulz H; Sachinidis A
Stem Cells Dev; 2012 Sep; 21(13):2471-84. PubMed ID: 22420508
[TBL] [Abstract][Full Text] [Related]
22. DSG2 Is a Functional Cell Surface Marker for Identification and Isolation of Human Pluripotent Stem Cells.
Park J; Son Y; Lee NG; Lee K; Lee DG; Song J; Lee J; Kim S; Cho MJ; Jang JH; Lee J; Park JG; Kim YG; Kim JS; Lee J; Cho YS; Park YJ; Han BS; Bae KH; Han S; Kang B; Haam S; Lee SH; Lee SC; Min JK
Stem Cell Reports; 2018 Jul; 11(1):115-127. PubMed ID: 29910125
[TBL] [Abstract][Full Text] [Related]
23. Non-integrating episomal plasmid-based reprogramming of human amniotic fluid stem cells into induced pluripotent stem cells in chemically defined conditions.
Slamecka J; Salimova L; McClellan S; van Kelle M; Kehl D; Laurini J; Cinelli P; Owen L; Hoerstrup SP; Weber B
Cell Cycle; 2016; 15(2):234-49. PubMed ID: 26654216
[TBL] [Abstract][Full Text] [Related]
24. Human embryonic and induced pluripotent stem cells maintain phenotype but alter their metabolism after exposure to ROCK inhibitor.
Vernardis SI; Terzoudis K; Panoskaltsis N; Mantalaris A
Sci Rep; 2017 Feb; 7():42138. PubMed ID: 28165055
[TBL] [Abstract][Full Text] [Related]
25. Identification and characterization of adenovirus early region 1B-associated protein 5 as a surface marker on undifferentiated human embryonic stem cells.
Choi HS; Kim WT; Kim H; Kim JJ; Ko JY; Lee SW; Jang YJ; Kim SJ; Lee MJ; Jung HS; Kzhyshkowska J; Um SJ; Lee MY; Lee SH; Kim CH; Ryu CJ
Stem Cells Dev; 2011 Apr; 20(4):609-20. PubMed ID: 21083500
[TBL] [Abstract][Full Text] [Related]
26. Teratoma formation of human embryonic stem cells in three-dimensional perfusion culture bioreactors.
Stachelscheid H; Wulf-Goldenberg A; Eckert K; Jensen J; Edsbagge J; Björquist P; Rivero M; Strehl R; Jozefczuk J; Prigione A; Adjaye J; Urbaniak T; Bussmann P; Zeilinger K; Gerlach JC
J Tissue Eng Regen Med; 2013 Sep; 7(9):729-41. PubMed ID: 22438087
[TBL] [Abstract][Full Text] [Related]
27. Development of a decoy immunization strategy to identify cell-surface molecules expressed on undifferentiated human embryonic stem cells.
Choi HS; Kim H; Won A; Kim JJ; Son CY; Kim KS; Ko JH; Lee MY; Kim CH; Ryu CJ
Cell Tissue Res; 2008 Aug; 333(2):197-206. PubMed ID: 18560898
[TBL] [Abstract][Full Text] [Related]
28. Expression of pluripotent stem cell markers in the human fetal testis.
Kerr CL; Hill CM; Blumenthal PD; Gearhart JD
Stem Cells; 2008 Feb; 26(2):412-21. PubMed ID: 18024420
[TBL] [Abstract][Full Text] [Related]
29. Human mid-trimester amniotic fluid stem cells cultured under embryonic stem cell conditions with valproic acid acquire pluripotent characteristics.
Moschidou D; Mukherjee S; Blundell MP; Jones GN; Atala AJ; Thrasher AJ; Fisk NM; De Coppi P; Guillot PV
Stem Cells Dev; 2013 Feb; 22(3):444-58. PubMed ID: 23050522
[TBL] [Abstract][Full Text] [Related]
30. Pluripotent Stem Cell Heterogeneity.
Hayashi Y; Ohnuma K; Furue MK
Adv Exp Med Biol; 2019; 1123():71-94. PubMed ID: 31016596
[TBL] [Abstract][Full Text] [Related]
31. Phosphatase and tensin homolog regulates the pluripotent state and lineage fate choice in human embryonic stem cells.
Alva JA; Lee GE; Escobar EE; Pyle AD
Stem Cells; 2011 Dec; 29(12):1952-62. PubMed ID: 21948699
[TBL] [Abstract][Full Text] [Related]
32. Differential responses to retinoic acid and endocrine disruptor compounds of subpopulations within human embryonic stem cell lines.
Annab LA; Bortner CD; Sifre MI; Collins JM; Shah RR; Dixon D; Karimi Kinyamu H; Archer TK
Differentiation; 2012 Nov; 84(4):330-43. PubMed ID: 22906706
[TBL] [Abstract][Full Text] [Related]
33. Cells derived from human umbilical cord blood support the long-term growth of undifferentiated human embryonic stem cells.
Zhan X; Hill C; Brayton CF; Shamblott MJ
Cloning Stem Cells; 2008 Dec; 10(4):513-22. PubMed ID: 18823264
[TBL] [Abstract][Full Text] [Related]
34. Clonal isolation of an intermediate pluripotent stem cell state.
Chang KH; Li M
Stem Cells; 2013 May; 31(5):918-27. PubMed ID: 23341219
[TBL] [Abstract][Full Text] [Related]
35. Design of a Vitronectin-Based Recombinant Protein as a Defined Substrate for Differentiation of Human Pluripotent Stem Cells into Hepatocyte-Like Cells.
Nagaoka M; Kobayashi M; Kawai C; Mallanna SK; Duncan SA
PLoS One; 2015; 10(8):e0136350. PubMed ID: 26308339
[TBL] [Abstract][Full Text] [Related]
36. Strategies for enrichment and selection of stem cell-derived tissue precursors.
Bernstein HS; Hyun WC
Stem Cell Res Ther; 2012 May; 3(3):17. PubMed ID: 22575029
[TBL] [Abstract][Full Text] [Related]
37. Monkey embryonic stem cell lines expressing green fluorescent protein.
Takada T; Suzuki Y; Kondo Y; Kadota N; Kobayashi K; Nito S; Kimura H; Torii R
Cell Transplant; 2002; 11(7):631-5. PubMed ID: 12518890
[TBL] [Abstract][Full Text] [Related]
38. YAP Induces Human Naive Pluripotency.
Qin H; Hejna M; Liu Y; Percharde M; Wossidlo M; Blouin L; Durruthy-Durruthy J; Wong P; Qi Z; Yu J; Qi LS; Sebastiano V; Song JS; Ramalho-Santos M
Cell Rep; 2016 Mar; 14(10):2301-12. PubMed ID: 26947063
[TBL] [Abstract][Full Text] [Related]
39. In vitro reconstitution of germ cell development.
Li Y
Protein Cell; 2011 Dec; 2(12):944-5. PubMed ID: 22183809
[No Abstract] [Full Text] [Related]
40. Structure-based discovery of NANOG variant with enhanced properties to promote self-renewal and reprogramming of pluripotent stem cells.
Hayashi Y; Caboni L; Das D; Yumoto F; Clayton T; Deller MC; Nguyen P; Farr CL; Chiu HJ; Miller MD; Elsliger MA; Deacon AM; Godzik A; Lesley SA; Tomoda K; Conklin BR; Wilson IA; Yamanaka S; Fletterick RJ
Proc Natl Acad Sci U S A; 2015 Apr; 112(15):4666-71. PubMed ID: 25825768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
